Marllon Cindra Sant'ANa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marllon Cindra Sant'ANa has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Carlos dos Santos
Department of Neurosciences and Behaviour Sciences Universidade de São Paulo, Hospital das Clínicas da Faculdade de Medicina de Ribeirão Preto Ribeirão Preto, São Paulo Brazil
2 shared publications - Carlos Alberto Scrideli
Department of Pediatrics, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, SP, Brazil
2 shared publications - Débora Dummer Meira
Federal University of Espírito Santo
2 shared publications - Elvis Terci Valera
Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil
2 shared publications - Iúri Drumond Louro
Federal University of Espírito Santo
2 shared publications - Mariana Maschietto
Research Center, Boldrini Children’s Hospital, Campinas 13083-884, SP, Brazil
2 shared publications
Latest Publications
- Open Access
- 4 July 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1)
Challenging anatomical paradigms: unexpected supratentorial localization of posterior fossa B ependymomas identified by DNA methylation
Molecular subgroups of ependymomas are strongly associated with their primary anatomical compartments, namely the supratentorial region, posterior fossa and spine locations. Although it is generally accepted that posterior fossa ependymomas may arise from radial glia-like progenitor cells, the precise cellular origin of the distinct posterior fossa molecular subgroups remains to be determined. Given that DNA methylation profile strongly recapitulates developmental lineage and the cell of origin, the characterization of unexpectedly located molecular subgroups of ependymomas may provide insights into their cells of origin and potential migratory dynamics during embryogenesis and brain development. Herein, we describe two male school-aged pediatric patients with supratentorial tumors located in the third ventricle/pineal region that were classified as posterior fossa group B ependymomas based on DNA methylation profiling. To our knowledge, this represents the first reports of posterior fossa group B ependymomas identified outside the posterior fossa compartment.
- 4 July 2026
- Published by Springer Nature in Acta Neuropathologica Communications
- Vol. 14 (1)
Open AccessChallenging anatomical paradigms: unexpected supratentorial localization of posterior fossa B ependymomas identified by DNA methylation
Molecular subgroups of ependymomas are strongly associated with their primary anatomical compartments, namely the supratentorial region, posterior fossa and spine locations. Although it is generally accepted that posterior fossa ependymomas may arise from radial glia-like progenitor cells, the precise cellular origin of the distinct posterior fossa molecular subgroups remains to be determined. Given that DNA methylation profile strongly recapitulates developmental lineage and the cell of origin, the characterization of unexpectedly located molecular subgroups of ependymomas may provide insights into their cells of origin and potential migratory dynamics during embryogenesis and brain development. Herein, we describe two male school-aged pediatric patients with supratentorial tumors located in the third ventricle/pineal region that were classified as posterior fossa group B ependymomas based on DNA methylation profiling. To our knowledge, this represents the first reports of posterior fossa group B ependymomas identified outside the posterior fossa compartment.
- Open Access
- 24 April 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (7) , e70364
Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion
- 24 April 2026
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 73 (7) , e70364
Open AccessFetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion
- Open Access
- 1 February 2024
- Published by Editora RECIMA21 LTDA in RECIMA21 - Revista Científica Multidisciplinar
- Vol. 5 (2) , e524797
BIOTECHNOLOGY AND GENETIC ENGINEERING: CURRENT ADVANCEMENTS, EMERGING CHALLENGES, AND FUTURE HORIZONS IN MODERN SCIENCE
Biotechnology is the term given to the branch of science that employs knowledge, techniques, and genetic engineering methods for creating various products using living organisms as raw material. Although this term has been recently adopted, humans have long been manipulating biological processes for their own benefit. Biotechnology is multidisciplinary and encompasses various fields of knowledge, with significant progress achieved over the years, particularly in the medical and cosmetic sectors. Through genetic engineering, it has become possible to edit genes more precisely, revolutionizing the study and manipulation of DNA and allowing the proposal and use of strategies that were once unthinkable in the scientific field to address contemporary issues. Among its most recent contributions are the development of new drugs and biopharmaceuticals, vaccines, cellular, genetic, and protein therapies, as well as the production of biocosmetics. However, there are still challenges to be faced in the extensive use of genetic engineering, ranging from production costs and the success of the technique at the molecular level to ethical issues surrounding the application of this technology. Thus, this literature review aims to discuss the most recent advances, applications, and future perspectives of biotechnology and genetic engineering in the scientific field.
- 1 February 2024
- Published by Editora RECIMA21 LTDA in RECIMA21 - Revista Científica Multidisciplinar
- Vol. 5 (2) , e524797
Open AccessBIOTECHNOLOGY AND GENETIC ENGINEERING: CURRENT ADVANCEMENTS, EMERGING CHALLENGES, AND FUTURE HORIZONS IN MODERN SCIENCE
Biotechnology is the term given to the branch of science that employs knowledge, techniques, and genetic engineering methods for creating various products using living organisms as raw material. Although this term has been recently adopted, humans have long been manipulating biological processes for their own benefit. Biotechnology is multidisciplinary and encompasses various fields of knowledge, with significant progress achieved over the years, particularly in the medical and cosmetic sectors. Through genetic engineering, it has become possible to edit genes more precisely, revolutionizing the study and manipulation of DNA and allowing the proposal and use of strategies that were once unthinkable in the scientific field to address contemporary issues. Among its most recent contributions are the development of new drugs and biopharmaceuticals, vaccines, cellular, genetic, and protein therapies, as well as the production of biocosmetics. However, there are still challenges to be faced in the extensive use of genetic engineering, ranging from production costs and the success of the technique at the molecular level to ethical issues surrounding the application of this technology. Thus, this literature review aims to discuss the most recent advances, applications, and future perspectives of biotechnology and genetic engineering in the scientific field.
- Open Access
Biomarkers in Breast Cancer: An Old Story with a New End
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk prediction, enabling personalized treatments, improving therapy, and preventing overtreatment, undertreatment, and incorrect treatment. Several breast cancer biomarkers have been identified and, along with traditional biomarkers, they can assist physicians throughout treatment plan and increase therapy success. Despite the need of more data to improve specificity and determine the real clinical utility of some biomarkers, others are already established and can be used as a guide to make treatment decisions. In this review, we summarize the available traditional, novel, and potential biomarkers while also including gene expression profiles, breast cancer single-cell and polyploid giant cancer cells. We hope to help physicians understand tumor specific characteristics and support decision-making in patient-personalized clinical management, consequently improving treatment outcome.
Open AccessBiomarkers in Breast Cancer: An Old Story with a New End
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk prediction, enabling personalized treatments, improving therapy, and preventing overtreatment, undertreatment, and incorrect treatment. Several breast cancer biomarkers have been identified and, along with traditional biomarkers, they can assist physicians throughout treatment plan and increase therapy success. Despite the need of more data to improve specificity and determine the real clinical utility of some biomarkers, others are already established and can be used as a guide to make treatment decisions. In this review, we summarize the available traditional, novel, and potential biomarkers while also including gene expression profiles, breast cancer single-cell and polyploid giant cancer cells. We hope to help physicians understand tumor specific characteristics and support decision-making in patient-personalized clinical management, consequently improving treatment outcome.